Tau in Late-Life Depression: A Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Abstract
A lifetime history of major depressive disorder (MDD) increases the risk of developing Alzheimer's disease, of which neurofibrillary tangles due to abnormal tau proteins are a hallmark. We systematically reviewed the literature on tau in MDD and identified 49 relevant articles spanning a number of modalities, including cerebrospinal fluid (CSF) analysis, positron emission tomography, and clinicopathological correlation. We compared CSF total and phosphorylated tau proteins in MDD and controls using a meta-analytic approach. We found no difference in total or phosphorylated tau in MDD. We also found no difference in a comparison of a subgroup excluding studies with significant age differences. Positron emission tomography studies lacked specificity. Clinicopathological studies failed to associate neurofibrillary tangles with MDD. The available data on tau in MDD is limited. The involvement of tau in a subset of MDD cannot be ruled out and requires prospective exploration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, there were no differences between LLD patients and healthy controls in CSF total and phosphorylated tau125.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [125]
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 2×
“in the pathophysiology of depression [1].”
BackgroundStaging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Depression in Late Life: Review and Commentary
Blazer, D. G. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.3.m249 · Cited by 2,344
Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · cited 3×
“Elevated t-tau reflects axonal degeneration, and, in addition to AD, it occurs in stroke, trauma, and encephalitis as a result of acute brain damage [25].”
BackgroundInfluentialOwnby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · cited 4×
“There is mounting evidence showing a complex interaction between late-life MDD with Alzheimer’s disease (AD) [2, 3].”
BackgroundResultInfluentialAlzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Mandelkow, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01368-3 · Cited by 953
The pathological process underlying Alzheimer’s disease in individuals under thirty
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812 · cited 1×
“Tau protein misfolding may occur in individuals as early as before puberty to young adulthood [19].”
BackgroundBlennow, K., Wallin, A., Ågren, H., Spenger, C., Siegfried, J., & Vanmechelen, E. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815140 · Cited by 789
PET of Brain Amyloid and Tau in Mild Cognitive Impairment
Small, G. W., Kepe, V., Ercoli, L. M., Siddarth, P., Bookheimer, S. Y., Miller, K. J., Lavretsky, H., Burggren, A. C., Cole, G. M., Vinters, H. V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054625 · Cited by 738
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
Chien, D. T., Szardenings, A. K., Bahri, S., Walsh, J. C., Mu, F., Xia, C., Shankle, W. R., Lerner, A. J., Su, M.-Y., Elizarov, A., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130098 · Cited by 675
Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807
Chien, D. T., Bahri, S., Szardenings, A. K., Walsh, J. C., Mu, F., Su, M.-Y., Shankle, W. R., Elizarov, A., & Kolb, H. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122059 · Cited by 651
Depression as a Risk Factor for Alzheimer Disease: The MIRAGE Study
Green, R. C., Cupples, L. A., Kurz, A., Auerbach, S., Go, R., Sadovnick, D., Duara, R., Kukull, W. A., Chui, H., Edeki, T., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.753 · Cited by 551 · cited 1×
“There is mounting evidence showing a complex interaction between late-life MDD with Alzheimer’s disease (AD) [2, 3].”
BackgroundPathways linking late-life depression to persistent cognitive impairment and dementia
Butters, M. A., Young, J. B., Lopez, O., Aizenstein, H. J., Mulsant, B. H., Reynolds III, C. F., DeKosky, S. T., & Becker, J. T. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.3/mabutters · Cited by 534
The neuropathology of aminergic nuclei in Alzheimer's disease
Zweig, R. M., Ross, C. A., Hedreen, J. C., Steele, C., Cardillo, J. E., Whitehouse, P. J., Folstein, M. F., & Price, D. L. (1988) · Annals of Neurology · doi:10.1002/ana.410240210 · Cited by 446
Sjögren, M., Vanderstichele, H., Ågren, H., Zachrisson, O., Edsbagge, M., Wikkelsø, C., Skoog, I., Wallin, A., Wahlund, L.-O., Marcusson, J., et al. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1776 · Cited by 436
Whitwell, J. L., Dickson, D. W., Murray, M. E., Weigand, S. D., Tosakulwong, N., Senjem, M. L., Knopman, D. S., Boeve, B. F., Parisi, J. E., Petersen, R. C., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70200-4 · Cited by 419
Kessing, L. V. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.031773 · Cited by 406
Rapp, M. A., Schnaider-Beeri, M., Grossman, H. T., Sano, M., Perl, D. P., Purohit, D. P., Gorman, J. M., & Haroutunian, V. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.161 · Cited by 386
Affective disorders and risk of developing dementia: systematic review
da Silva, J., Gonçalves-Pereira, M., Xavier, M., & Mukaetova-Ladinska, E. B. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.101931 · Cited by 327
Sjögren, M., Minthon, L., Davidsson, P., Granérus, A. K., Clarberg, A., Vanderstichele, H., Vanmechelen, E., Wallin, A., & Blennow, K. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070079 · Cited by 239
Memory and mental status correlates of modified Braak staging
Grober, E., Dickson, D., Sliwinski, M. J., Buschke, H., Katz, M., Crystal, H., & Lipton, R. B. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00063-9 · Cited by 236
d-serine levels in Alzheimer’s disease: implications for novel biomarker development
Madeira, C., Lourenco, M. V., Vargas-Lopes, C., Suemoto, C. K., Brandão, C. O., Reis, T., Leite, R. E. P., Laks, J., Jacob-Filho, W., Pasqualucci, C. A., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.52 · Cited by 229
Neuropsychological Differences Between Late-Onset and Recurrent Geriatric Major Depression
Rapp, M. A., Dahlman, K., Sano, M., Grossman, H. T., Haroutunian, V., & Gorman, J. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.691 · Cited by 219
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
Andreasen, N., Minthon, L., Clarberg, A., Davidsson, P., Gottfries, J., Vanmechelen, E., Vanderstichele, H., Winblad, B., & Blennow, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1488 · Cited by 212
Memory complaints are related to Alzheimer disease pathology in older persons
Barnes, L. L., Schneider, J. A., Boyle, P. A., Bienias, J. L., & Bennett, D. A. (2006) · Neurology · doi:10.1212/01.wnl.0000242734.16663.09 · Cited by 193
Neuropathological correlates of late-life depression in older people
Tsopelas, C., Stewart, R., Savva, G. M., Brayne, C., Ince, P., Thomas, A., & Matthews, F. E. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078816 · Cited by 182 · cited 3×
“[65] found no difference in late-onset MDD despite a broad search (see Table 3).”
BackgroundIncreased Neurofibrillary Tangles in Patients With Alzheimer Disease With Comorbid Depression
Rapp, M. A., Schnaider-Beeri, M., Purohit, D. P., Perl, D. P., Haroutunian, V., & Sano, M. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31816029ec · Cited by 178
Reynolds, C. F., Butters, M. A., Lopez, O., Pollock, B. G., Dew, M. A., Mulsant, B. H., Lenze, E. J., Holm, M., Rogers, J. C., Mazumdar, S., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.184 · Cited by 171 · cited 1×
“Identifying which patients presenting with MDD have underlying AD pathology, including amyloid plaques and neurofibrillary tangles due to abnormal tau proteins, would enable early intervention [4].”
BackgroundBlasko, I., Lederer, W., Oberbauer, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J., & Humpel, C. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089137 · Cited by 170
Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
van Harten, A. C., Kester, M. I., Visser, P.-J., Blankenstein, M. A., Pijnenburg, Y. A. L., van der Flier, W. M., & Scheltens, P. (2011) · cclm · doi:10.1515/cclm.2011.086 · Cited by 167
Clinical-pathologic study of depressive symptoms and cognitive decline in old age
Wilson, R. S., Capuano, A. W., Boyle, P. A., Hoganson, G. M., Hizel, L. P., Shah, R. C., Nag, S., Schneider, J. A., Arnold, S. E., & Bennett, D. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000715 · Cited by 165
Relationship Between Tau Pathology and Neuroinflammation in Alzheimer's Disease
Metcalfe, M. J., & Figueiredo‐Pereira, M. E. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20163 · Cited by 158
Geriatric depression: Age of onset and dementia
Alexopoulos, G. S., Young, R. C., & Meyers, B. S. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90383-o · Cited by 155
Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease
Welge, V., Fiege, O., Lewczuk, P., Mollenhauer, B., Esselmann, H., Klafki, H.-W., Wolf, S., Trenkwalder, C., Otto, M., Kornhuber, J., et al. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-008-0177-6 · Cited by 152
Pomara, N., Bruno, D., Sarreal, A. S., Hernando, R. T., Nierenberg, J., Petkova, E., Sidtis, J. J., Wisniewski, T. M., Mehta, P. D., Pratico, D., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11081153 · Cited by 143
Hertze, J., Minthon, L., Zetterberg, H., Vanmechelen, E., Blennow, K., & Hansson, O. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100207 · Cited by 134
Hendricksen, M., Thomas, A. J., Ferrier, I. N., Ince, P., & O’Brien, J. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1096 · Cited by 121
Neuropathologic Correlates of Late-Onset Major Depression
Sweet, R. A., Hamilton, R. L., Butters, M. A., Mulsant, B. H., Pollock, B. G., Lewis, D. A., López, O. L., DeKosky, S. T., & Reynolds, C. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300554 · Cited by 119
The Relationship Between Cerebrospinal Fluid Biomarkers and Depression in Elderly Women
Gudmundsson, P., Skoog, I. G., Wærn, M., Blennow, K., Palsson, S. P., Rosengren, L., & Gustafson, D. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3180547091 · Cited by 119
Chou, Y.-Y., Leporé, N., Avedissian, C., Madsen, S. K., Parikshak, N., Hua, X., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., Toga, A. W., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.02.015 · Cited by 117
Ramakers, I. H. G. B., Verhey, F. R. J., Scheltens, P., Hampel, H., Soininen, H., Aalten, P., Rikkert, M. O., Verbeek, M. M., Spiru, L., Blennow, K., et al. (2013) · Psychological Medicine · doi:10.1017/s0033291712001870 · Cited by 115
Silver, M. H., Newell, K., Brady, C., Hedley-White, E. T., & Perls, T. T. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200205000-00014 · Cited by 110
Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation
Halliday, G. M., McCann, H., Pamphlett, R., Brooks, W. S., Creasey, H. M., McCusker, E. A., Cotton, R. G. H., Broe, G. A., & Harper, C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227741 · Cited by 109
Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons
Wilson, R. S., Schneider, J. A., Bienias, J. L., Arnold, S. E., Evans, D. A., & Bennett, D. A. (2003) · Neurology · doi:10.1212/01.wnl.0000092914.04345.97 · Cited by 109
Lavretsky, H., Siddarth, P., Kepe, V., Ercoli, L. M., Miller, K. J., Burggren, A. C., Bookheimer, S. Y., Huang, S.-C., Barrio, J. R., & Small, G. W. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181953b82 · Cited by 108
Buerger, K., Zinkowski, R., Teipel, S. J., Arai, H., DeBernardis, J., Kerkman, D., McCulloch, C., Padberg, F., Faltraco, F., Goernitz, A., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.376 · Cited by 92
Amyloid-beta and depression in healthy older adults: A systematic review
Harrington, K. D., Lim, Y. Y., Gould, E., & Maruff, P. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414557161 · Cited by 87
Protein Binding in Patients With Late-Life Depression
Kumar, A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.122 · Cited by 86
Structural brain changes associated with depressive symptoms in the elderly with Alzheimer's disease
Lebedeva, A., Westman, E., Lebedev, A. V., Li, X., Winblad, B. G., Simmons, A., Wahlund, L., Aarsland, D., & Initiative, A. D. N. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307110 · Cited by 82
Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?
Mahgoub, N., & Alexopoulos, G. S. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.12.003 · Cited by 81
Pragmatism Instead of Mechanism: A Call for Impactful Biological Psychiatry
Paulus, M. P. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0497 · Cited by 79
Buch, K., Padberg, F., Nolde, T., Teipel, S. J., Stübner, S., Haslinger, A., Schwarz, M., Sunderland, T., Arai, H., Rapoport, S. I., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00845-9 · Cited by 76
Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease
Skogseth, R., Mulugeta, E., Ballard, C., Rongve, A., Nore, S., Alves, G., & Aarsland, D. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000137671 · Cited by 71 · cited 1×
“[54] Cross-sectional To explore psychiatric symptoms correlated with CSF biomarkers in AD.”
BackgroundNascimento, K. K. F. D., Silva, K. P., Malloy-Diniz, L. F., Butters, M. A., & Diniz, B. S. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.07.024 · Cited by 69
Diniz, B. S., Teixeira, A. L., Machado-Vieira, R., Talib, L. L., Radanovic, M., Gattaz, W. F., & Forlenza, O. V. (2014) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/gbu096 · Cited by 67
Schönknecht, P., Pantel, J., Kaiser, E., Thomann, P. A., & Schröder, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.070 · Cited by 66
Chung, J. K., Initiative, F. T. A. D. N., Plitman, E., Nakajima, S., Chow, T. W., Chakravarty, M. M., Caravaggio, F., Gerretsen, P., Brown, E. E., Iwata, Y., et al. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142931 · Cited by 65
Self-citationPlasma biomarkers of depressive symptoms in older adults
Arnold, S. E., Xie, S. X., Leung, Y.-Y., Wang, L.-S., Kling, M. A., Han, X., Kim, E. J., Wolk, D. A., Bennett, D. A., Chen-Plotkin, A., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2011.63 · Cited by 65
Stefani, A., Martorana, A., Bernardini, S., Panella, M., Mercati, F., Orlacchio, A., & Pierantozzi, M. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.09.014 · Cited by 63
Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI
Wolfsgruber, S., Jessen, F., Koppara, A., Kleineidam, L., Schmidtke, K., Frölich, L., Kurz, A., Schulz, S., Hampel, H., Heuser, I., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001399 · Cited by 63
Depression subtypes and 5‐year risk of dementia and Alzheimer disease in patients aged 70 years
Vilalta‐Franch, J., López‐Pousa, S., Llinàs‐Reglà, J., Calvó‐Perxas, L., Merino‐Aguado, J., & Garre‐Olmo, J. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3826 · Cited by 60
Ivanoiu, A., & Sindic, C. J. M. (2005) · Neurocase · doi:10.1080/13554790490896901 · Cited by 60
Brainstem Aminergic Nuclei and Late-Life Depressive Symptoms
Wilson, R. S., Nag, S., Boyle, P. A., Hizel, L. P., Yu, L., Buchman, A. S., Shah, R. C., Schneider, J. A., Arnold, S. E., & Bennett, D. A. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2224 · Cited by 60
Schönknecht, P., Pantel, J., Hartmann, T., Werle, E., Volkmann, M., Essig, M., Amann, M., Zanabili, N., Bardenheuer, H. J., Hunt, A., et al. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00197-5 · Cited by 59
Blood‐based neurochemical diagnosis of vascular dementia: a pilot study
Bibl, M., Esselmann, H., Mollenhauer, B., Weniger, G., Welge, V., Liess, M., Lewczuk, P., Otto, M., Schulz, J. B., Trenkwalder, C., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04763.x · Cited by 58
Auning, E., Selnes, P., Grambaitė, R., Benth, J. Š., Haram, A., Stav, A. L., Bjørnerud, A., Hessen, E., Hol, P. K., Løndalen, A. M., et al. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12352 · Cited by 49
Royall, D., & Palmer, R. F. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.11.009 · Cited by 48
O’Brien, J., Thomas, A., Ballard, C., Brown, A., Ferrier, N., Jaros, E., & Perry, R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00944-6 · Cited by 46
Paraskevas, G. P., Kapaki, E. N., Liappas, I., Theotoka, I., Mamali, I., Zournas, C., & Lykouras, L. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705277549 · Cited by 45
Hypocretin in cerebrospinal fluid is positively correlated with Tau and pTau
Deuschle, M., Schilling, C., Leweke, F. M., Enning, F., Pollmächer, T., Esselmann, H., Wiltfang, J., Frölich, L., & Heuser, I. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.036 · Cited by 44
Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease.
Almkvist, O., & Tallberg, I. (2009) · Neuropsychology · doi:10.1037/a0014074 · Cited by 43
Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress
Yang, C., Guo, X., Wang, G. H., Wang, H. L., Liu, Z. C., Liu, H., Zhu, Z. X., & Li, Y. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20133275 · Cited by 40
Reis, T., Brandão, C. O., Coutinho, E. S. F., Engelhardt, E., & Laks, J. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00311.x · Cited by 34
Stuerenburg, H. J., Ganzer, S., & Müller‐Thomsen, T. (2004) · PubMed · Cited by 25
Depression in the elderly: pathological study of raphe and locus ceruleus
Syed, A., Chatfield, M., Matthews, F., Harrison, P., Brayne, C., & Esiri, M. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00662.x · Cited by 24
Neuroanatomy of Alzheimer's disease: Hierarchical vulnerability and neural system compromise
Hoesen, G. W. V., Solodkin, A., & Hyman, B. T. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00019-b · Cited by 24
Damadzic, R., Shuangshoti, S., Giblen, G., & Herman, M. M. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0496-2 · Cited by 22
Differential FDDNP PET Patterns in Nondemented Middle-Aged and Older Adults
Ercoli, L. M., Siddarth, P., Kepe, V., Miller, K. J., Huang, S. C., Cole, G. M., Lavretsky, H., Bookheimer, S. Y., Kim, J., Phelps, M. E., et al. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318198750b · Cited by 19
Sorensen, K. C. N., Simonsen, A. H., Holmetoft, U. B., Hasselbalch, S. G., & Heegaard, N. H. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122410 · Cited by 12
Clarke, N. A., Hartmann, T., Jones, E. L., Ballard, C. G., & Francis, P. T. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2678 · Cited by 10
Cited by
Mechanisms and treatment of late-life depression
Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592
Depression in Alzheimer’s Disease: Epidemiology, Mechanisms, and Treatment
Huang, Y.-Y., Gan, Y.-H., Yang, L., Cheng, W., & Yu, J.-T. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.10.008 · Cited by 164
Gatchel, J. R., Donovan, N. J., Locascio, J. J., Schultz, A. P., Becker, J. A., Chhatwal, J., Papp, K. V., Amariglio, R. E., Rentz, D. M., Blacker, D., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170001 · Cited by 124
Repetitive negative thinking is associated with amyloid, tau, and cognitive decline
Marchant, N. L., Lovland, L. R., Jones, R., Binette, A. P., Gonneaud, J., Arenaza‐Urquijo, E. M., Chételat, G., & Villeneuve, S. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12116 · Cited by 120
Babulal, G. M., Roe, C. M., Stout, S. H., Rajasekar, G., Wisch, J. K., Benzinger, T. L. S., Morris, J. C., & Ances, B. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191078 · Cited by 115
Metadata
- Authors
- Brown, E. E., Iwata, Y., Chung, J. K., Gerretsen, P., & Graff-Guerrero, A.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Department of Psychiatry, University of Toronto, Toronto, ON, Canada
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2016-09-06
- Volume
- 54
- Issue
- 2
- Pages
- 615-633
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2491401762
- Cited by
- 29
- References
- 88
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 1
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- tau protein, major depressive disorder
- MeSH terms
- Aged, Aged, 80 and over, Cross-Sectional Studies, Depression, Humans, Longitudinal Studies, Biomarkers, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.